TUBA4A and hepatocellular carcinoma: Co-IP assays using antibody targeting endogenous or Flag-tagged HKDC1 showed that it could indeed interact with ACTA2, but not TUBA4A, in HCC cells (Fig. 4c and Supplementary Fig. 5a, b).